Navigation Links
Beekeepers, Growers Laud Bayer CropScience’s New Fluency Agent
Date:11/19/2013

5-4521
Email: catharine(dot)montgomery(at)porternovelli(dot)com

USA-BCS-2013-0332

Find more information at bayercropscience.us.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11339037.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Beekeepers, Researchers and Bayer CropScience Associate Overwintering Bee Losses with Varroa Mite
2. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
3. Biotechnology guaranteed US$ 100 K to average Brazilian corn growers in four years, according to ABRASEM
4. Seeing is Believing for Growers at Bayer CropScience Respect the Rotation Events
5. New HBK LibertyLink Varieties from Bayer CropScience Help Southern Soybean Growers Combat Weed Resistance
6. Bayer CropScience Honors Cotton Growers at FiberMax One Ton Club
7. Bayer CropScience Debuts Serenade Optimum to Help Growers Control Tough Diseases and Combat Resistance
8. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
9. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
10. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
11. Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015 Forskare ... 2015 på  http://www.openinnovationinscience.at till det återkommande ... som hålls i Wien ... med internationella forskare och vetenskapsmän som genomfördes ... två största utmaningar bristen på incitament för ...
(Date:7/2/2015)... , ... July 03, 2015 , ... Cuvettes have been used in countless labs for ... to find the cuvette they needed. As expected, this was a daunting and tiring ... wrong part because they were not able to navigate the complex catalog structure. , Now ...
(Date:7/2/2015)... ... July 02, 2015 , ... Sleepless nights will become obsolete as Luzi ... its Indiegogo campaign on June 23. Sound sleepers and the sleep deprived both will ... to use, while the integration of the Bluetooth speaker, alarm clock and ability to ...
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3New Cuvette E-Commerce Website Launched by FireflySci 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3
... 5 Delcath Systems, Inc. (Nasdaq: DCTH ... company focused on oncology, highlighted the Phase III trial ... American Society of Clinical Oncology,s 2010 Annual Meeting, comparing ... care for patients with hepatic metastases from ocular or cutaneous ...
... Genomic Health, Inc. (Nasdaq: GHDX ) today ... American Society of Clinical Oncology (ASCO) Annual Meeting, including an ... III colon cancer, suggesting a potential role for the Onco ... III disease, pending further study. The company also announced the ...
... HUNTINGTON BEACH, California and AMSTERDAM , June ... diagnostics, today announced that,researchers from Agendia and leading academic centers ... multiple studies concerning Agendia,s assays,MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the ... 8, 2010 , at McCormick Place in, Chicago . MammaPrint, ...
Cached Biology Technology:Delcath Highlights Phase III Trial Results Presented at ASCO 2Delcath Highlights Phase III Trial Results Presented at ASCO 3Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 5Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 6Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 7Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 8Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting 9Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual Meeting 2Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual Meeting 3
(Date:6/24/2015)... YORK , June 24, 2015 This ... market, over the next six years. It contains an ... the industry, along with their impact from the short, ... It also discusses the industry, market, and technology trends ... that the need of concerned authorities to efficiently manage ...
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... the first time, the upper safe limit of vitamin ... events or death raises significantly, according to a recent ... Journal of Clinical Endocrinology & Metabolism ( JCEM ... plays a pivotal role in human physiology. Vitamin D ...
... in obese laboratory rats may provide a less-invasive alternative ... Endocrinology . Scientists at Cincinnati Children,s Hospital ... of bile from the bile duct into the small ... bariatric surgeries such as gastric by-pass. They named the ...
... the selected highlights for the May 2013 issue of the ... May issue is available online at http://www.genetics.org/content/current . ... 2013. Please feel free to forward to colleagues ... array of topics including: developmental and behavioral genetics; genome integrity ...
Cached Biology News:Researchers pinpoint upper safe limit of vitamin D blood levels 2Study finds possible alternative to bariatric weight loss surgery 2Genetics Society of America's GENETICS journal highlights for May 2013 2Genetics Society of America's GENETICS journal highlights for May 2013 3Genetics Society of America's GENETICS journal highlights for May 2013 4Genetics Society of America's GENETICS journal highlights for May 2013 5
...
... anti-viral agent. Inhibits several important steps of angiogenesis ... HUVEC cells. Also reduces intracellular reactive oxygen species ... of endothelial cells. Formula: ... 8 MolWeight: ...
22 x 50 mm; No. 1 thickness range: 0.13 to 0.17 mm, suitable for work in histology, cytology, urinalysis and microbiology, precleaned, store at room temperature ...
G-Protein Coupled Receptor Assay, For 500 assays. SPA. Category: Drug Screening & Cellular Assays, Assays ....
Biology Products: